1. Home
  2. RDWR vs ABCL Comparison

RDWR vs ABCL Comparison

Compare RDWR & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radware Ltd.

RDWR

Radware Ltd.

HOLD

Current Price

$24.14

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.05

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDWR
ABCL
Founded
1996
2012
Country
Israel
Canada
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
RDWR
ABCL
Price
$24.14
$3.05
Analyst Decision
Hold
Buy
Analyst Count
3
5
Target Price
$32.50
$7.75
AVG Volume (30 Days)
231.6K
3.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$28,833,000.00
Revenue This Year
$10.29
$26.18
Revenue Next Year
$7.85
$13.51
P/E Ratio
$59.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.46
$1.89
52 Week High
$30.57
$6.52

Technical Indicators

Market Signals
Indicator
RDWR
ABCL
Relative Strength Index (RSI) 47.27 40.69
Support Level $25.47 $3.06
Resistance Level $28.81 $3.24
Average True Range (ATR) 1.30 0.21
MACD -0.06 -0.01
Stochastic Oscillator 21.15 39.68

Price Performance

Historical Comparison
RDWR
ABCL

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. It generates the majority of its revenue from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: